SST and neoplasm: Depending on the primary tumour location, histopathological features, and somatostatin receptor status, we have now a variety of treatment option including “cold” somatostatin analogues, mTOR inhibitors, and kinase inhibitors, as well as somatostatin-based radiotherapy.